Stay updated on PD1 Inhibitor+Vitamin D in Pancreatic Cancer Maintenance Clinical Trial
Sign up to get notified when there's something new on the PD1 Inhibitor+Vitamin D in Pancreatic Cancer Maintenance Clinical Trial page.

Latest updates to the PD1 Inhibitor+Vitamin D in Pancreatic Cancer Maintenance Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page history shows a new revision entry (v3.3.4) added and the previous revision (v3.3.3) removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedThe page footer now shows Revision: v3.3.3, and the HHS Vulnerability Disclosure link and Revision: v3.3.2 have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check36 days agoChange DetectedAdded new sections for Contacts/Locations and Study Status to the record history on 2025-12-15; the prior update from 2025-10-21 was removed.SummaryDifference0.3%

- Check58 days agoChange DetectedRevision history shows an added entry for v3.3.2 and removal of v3.2.0, which are metadata changes to the page rather than study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check65 days agoChange DetectedRemoved the government funding status notice banner from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check79 days agoChange DetectedNew version entry added to the Record History, reflecting updated study status and contact/locations. The history now shows the most recent submission data.SummaryDifference0.1%

Stay in the know with updates to PD1 Inhibitor+Vitamin D in Pancreatic Cancer Maintenance Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD1 Inhibitor+Vitamin D in Pancreatic Cancer Maintenance Clinical Trial page.